bay h 4502 and Neoplasms

bay h 4502 has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L1
Bates, SE; Curt, KM; Gottesman, MM; Kozlowski, H; McDonald, AJ; Patel, RP; Robey, RW; Sackett, DL1

Reviews

1 review(s) available for bay h 4502 and Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction

2015

Other Studies

1 other study(ies) available for bay h 4502 and Neoplasms

ArticleYear
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor models.
    Experimental cell research, 2019, 02-15, Volume: 375, Issue:2

    Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Clotrimazole; Depsipeptides; Drug Synergism; HCT116 Cells; Hexokinase; Histone Deacetylases; Humans; Imidazoles; Mitochondria; Neoplasms; Protein Transport

2019